Chicago Partners Investment Group’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,209
Closed -$11.9K 1309
2025
Q3
$11.9K Buy
14,209
+1,928
+16% +$1.9K ﹤0.01% 1213
2025
Q2
$12.5K Sell
12,281
-1,162
-9% -$1.17K ﹤0.01% 1093
2025
Q1
$11.9K Sell
13,443
-171
-1% -$180 ﹤0.01% 928
2024
Q4
$13.2K Sell
13,614
-1,371
-9% -$1.34K ﹤0.01% 845
2024
Q3
$15.7K Sell
14,985
-4,099
-21% -$4.5K ﹤0.01% 793
2024
Q2
$22.6K Sell
19,084
-11,583
-38% -$10K ﹤0.01% 741
2024
Q1
$27K Sell
30,667
-169
-0.5% -$164 ﹤0.01% 728
2023
Q4
$27.4K Sell
30,836
-5,522
-15% -$8.2K ﹤0.01% 693
2023
Q3
$67.4K Buy
36,358
+16,598
+84% +$47.6K ﹤0.01% 636
2023
Q2
$66.2K Buy
19,760
+9,262
+88% +$29.3K ﹤0.01% 667
2023
Q1
$28.8K Sell
10,498
-4,707
-31% -$14.1K ﹤0.01% 655
2022
Q4
$59.5K Buy
15,205
+2,021
+15% +$3K ﹤0.01% 627
2022
Q3
$20K Buy
13,184
+1,371
+12% +$2.68K ﹤0.01% 579
2022
Q2
$27K Sell
11,813
-613
-5% -$1.41K ﹤0.01% 586
2022
Q1
$28K Buy
+12,426
New +$44.5K ﹤0.01% 557

Other funds holding CTSO

Chicago Partners Investment Group's CTSO Position: Q4 2025 in Review

Chicago Partners Investment Group sold out of Cytosorbents Corp (CTSO) in Q4 2025, closing a stake of 14,209 shares — an estimated $11.9K sold.

Chicago Partners Investment Group first reported a position in CTSO in Q1 2022 and held it in 15 quarters. The position peaked at $67.4K in Q3 2023. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2025.

  • Chicago Partners Investment Group reported no remaining Cytosorbents Corp position as of Q4 2025 after selling out during the quarter.
  • Chicago Partners Investment Group sold 14,209 Cytosorbents Corp shares in Q4 2025, an estimated $11.9K.
  • Chicago Partners Investment Group first reported a position in Cytosorbents Corp in Q1 2022 and held it in 15 quarters.
  • Chicago Partners Investment Group's Cytosorbents Corp position peaked at $67.4K in Q3 2023.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2025.

Based on Chicago Partners Investment Group's 13F filing for Q4 2025, filed 28 Jan 2026.